Yu LM, Zhang WH, Han XX et al (2019) Hypoxia-induced ROS contribute to myoblast pyroptosis during obstructive sleep apnea via the NF-B/HIF-1 signaling pathway
Safety and efficacy of glucagon-like peptide-1 receptor agonists in patients with obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials
Known side effects include: The most common adverse reactions were reported in 5% of patients treated with Zepbound
This shows that GLP-1-based therapies, besides providing glycemic control, also plays a significant role in the maintenance of endothelial function and vascular health
There was a higher proportion of serious adverse events (SAEs) reported among the older subgroup without obesity (11.8%) compared with that of the overall population (8.1%), whereas the proportions of deaths were equivalent between the older subgroup without obesity (1.7%) and overall population (1.0%)
Thinking about the reasons why you want to consider going on a GLP-1 are important